Jump to main content
Jump to site search

Issue 2, 2014
Previous Article Next Article

Screening for mutations in BRCA1 and BRCA2 genes by measuring the acoustic ratio with QCM

Author affiliations

Abstract

Screening for mutations in the tumor-suppressor genes BRCA1 and BRCA2 is of great importance for breast and ovarian cancer prevention. We describe a methodology for mutation screening and detection based on acoustic wave devices. In particular, we detect four mutations located in BRCA1 and BRCA2 genes using the quartz crystal microbalance technique. The detection is based on measurements of the acoustic ratio of dissipation versus frequency change (ΔDF) of double-stranded DNA molecules bound to the device surface that are produced after PCR amplification and restriction digestion; the acoustic ratio has been shown to be a measure of the intrinsic viscosity of the attached molecules, which, in turn, depends on the size of the dsDNAs. Novel features of this approach are the lack of a hybridization step, the label free sensing of the length, rather than mass, of the DNA molecules and the direct detection of the digested DNA products without prior purification. The method is generic, simple and capable of detecting single base mutations to long genomic rearrangements; it is also suitable and applicable to a Lab-on-a-chip concept.

Graphical abstract: Screening for mutations in BRCA1 and BRCA2 genes by measuring the acoustic ratio with QCM

Back to tab navigation

Publication details

The article was received on 10 Jul 2013, accepted on 12 Sep 2013 and first published on 12 Sep 2013


Article type: Paper
DOI: 10.1039/C3AY41143E
Citation: Anal. Methods, 2014,6, 363-371
  •   Request permissions

    Screening for mutations in BRCA1 and BRCA2 genes by measuring the acoustic ratio with QCM

    G. Papadakis and E. Gizeli, Anal. Methods, 2014, 6, 363
    DOI: 10.1039/C3AY41143E

Search articles by author

Spotlight

Advertisements